More articles from Letters to the Editor

  • Antiobesity drug therapy
    Taher Modarressi, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 657; DOI: https://doi.org/10.3949/ccjm.88c.12001
  • Physician resistance to obesity pharmacotherapy
    Vania Modesto-Lowe, MD, Allison Wick, BS and Michael Dang, BS, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 658; DOI: https://doi.org/10.3949/ccjm.88c.12003
  • In Reply: Physician resistance to obesity pharmacotherapy
    Yael Mauer, MD, MPH, Marcie Parker, PharmD, BCACP and Sangeeta Kashyap, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 658-659; DOI: https://doi.org/10.3949/ccjm.88c.12004
  • In Reply: Antiobesity drug therapy
    Yael Mauer, MD, MPH, Marcie Parker, PharmD, BCACP and Sangeeta Kashyap, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 657-658; DOI: https://doi.org/10.3949/ccjm.88c.12002
  • In Reply: Prostate cancer screening
    Prasanna Sooriakumaran, MD, PhD, FRCSUrol, FEBU
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 261; DOI: https://doi.org/10.3949/ccjm.88c.05003

    Detection does not lead to overtreatment.

  • Prostate cancer screening
    Sherry Zhang, MD and Ian Jenkins, MD
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 260; DOI: https://doi.org/10.3949/ccjm.88c.05001

    The costs of PSA testing—both financial and to the patient’s well-being—are not worth it.

  • Prostate cancer screening
    Kevin Kurator, BS, BA and Ian Jenkins, MD
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 260; DOI: https://doi.org/10.3949/ccjm.88c.05002

    Screening should be advised only if benefits clearly outweigh the risks

  • In Reply: Prostate cancer screening
    Timothy Gilligan, MD
    Cleveland Clinic Journal of Medicine May 2021, 88 (5) 262; DOI: https://doi.org/10.3949/ccjm.88c.05004

    The debate about screening remains fraught, and passions run high on both sides.

  • COVID-19 coagulopathy
    Anup Katyal, MD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 712; DOI: https://doi.org/10.3949/ccjm.87c.12001

    Skepticism of high-intensity prophylaxis for patients with D-dimer ≥ 3.0 µg/mL.

  • Assessing stable coronary artery disease
    Taher Modarressi, MD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 713; DOI: https://doi.org/10.3949/ccjm.87c.12003

    Differences between the coronary calcium score and CT coronary angiography

Pages